Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia

Dhiren Singh1,2, Daniel W O’Connor11Department of Psychological Medicine, Monash University, Melbourne, Australia; 2Peninsula Mental Health Service, Melbourne, AustraliaAbstract: Antipsychotic medication is the mainstay of treatment in elderly patients with psychosis. In recent ye...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dhiren Singh, Daniel W O’Connor
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	risperidone long-acting injection old age efficacy safety Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/ca15521c93e94e37a1ca3efe95168343
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ca15521c93e94e37a1ca3efe95168343
record_format	dspace
spelling	oai:doaj.org-article:ca15521c93e94e37a1ca3efe951683432021-12-02T08:21:48ZEfficacy and safety of risperidone long-acting injection in elderly people with schizophrenia1178-1998https://doaj.org/article/ca15521c93e94e37a1ca3efe951683432009-08-01T00:00:00Zhttps://www.dovepress.com/efficacy-and-safety-of-risperidone-long-acting-injection-in-elderly-pe-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Dhiren Singh1,2, Daniel W O’Connor11Department of Psychological Medicine, Monash University, Melbourne, Australia; 2Peninsula Mental Health Service, Melbourne, AustraliaAbstract: Antipsychotic medication is the mainstay of treatment in elderly patients with psychosis. In recent years, second generation antipsychotics have come to be preferred. Longacting risperidone is the first such antipsychotic available for use in this vulnerable group of patients and offers an attractive alternative to traditional medications. The available literature revealed that long-acting risperidone is generally well tolerated and is effective in treating both the positive and negative symptoms of schizophrenia. Despite a lack of randomized trials and head-to-head studies, it appears to be a useful addition to the treatment armory for patients with chronic psychosis who require a depot preparation. Further research into its endocrine and metabolic side effects is needed.Keywords: risperidone, long-acting injection, old age, efficacy, safetyDhiren SinghDaniel W O’ConnorDove Medical Pressarticlerisperidonelong-acting injectionold ageefficacysafetyGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 4, Pp 351-355 (2009)
institution	DOAJ
collection	DOAJ
language	EN
topic	risperidone long-acting injection old age efficacy safety Geriatrics RC952-954.6
spellingShingle	risperidone long-acting injection old age efficacy safety Geriatrics RC952-954.6 Dhiren Singh Daniel W O’Connor Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
description	Dhiren Singh1,2, Daniel W O’Connor11Department of Psychological Medicine, Monash University, Melbourne, Australia; 2Peninsula Mental Health Service, Melbourne, AustraliaAbstract: Antipsychotic medication is the mainstay of treatment in elderly patients with psychosis. In recent years, second generation antipsychotics have come to be preferred. Longacting risperidone is the first such antipsychotic available for use in this vulnerable group of patients and offers an attractive alternative to traditional medications. The available literature revealed that long-acting risperidone is generally well tolerated and is effective in treating both the positive and negative symptoms of schizophrenia. Despite a lack of randomized trials and head-to-head studies, it appears to be a useful addition to the treatment armory for patients with chronic psychosis who require a depot preparation. Further research into its endocrine and metabolic side effects is needed.Keywords: risperidone, long-acting injection, old age, efficacy, safety
format	article
author	Dhiren Singh Daniel W O’Connor
author_facet	Dhiren Singh Daniel W O’Connor
author_sort	Dhiren Singh
title	Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
title_short	Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
title_full	Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
title_fullStr	Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
title_full_unstemmed	Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
title_sort	efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
publisher	Dove Medical Press
publishDate	2009
url	https://doaj.org/article/ca15521c93e94e37a1ca3efe95168343
work_keys_str_mv	AT dhirensingh efficacyandsafetyofrisperidonelongactinginjectioninelderlypeoplewithschizophrenia AT danielnbspworsquoconnor efficacyandsafetyofrisperidonelongactinginjectioninelderlypeoplewithschizophrenia
_version_	1718398568892465152

Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia

Ejemplares similares